How did Kariko and Weissman’s mRNA work enable Covid vaccines?

Question

Accepted Answer

Kariko and Weissman's mRNA Discoveries Enabled Covid-19 Vaccine Development Through Key Molecular Modifications

Katalin Kariko and Drew Weissman's foundational work on modifying messenger RNA (mRNA) molecules was crucial for the rapid development of Covid-19 vaccines. Their joint development of nucleoside base modifications in 2005 addressed a critical challenge by preventing the immune system from attacking synthetic mRNA, a significant hurdle that had previously limited the therapeutic application of mRNA technology. This breakthrough allowed for the effective use of mRNA as a tool to instruct human cells to produce specific proteins, paving the way for the unprecedented speed of vaccine creation during the pandemic.
Development of Nucleoside Base Modifications

In 2005, Kariko and Weissman collaborated to develop a method for modifying nucleoside bases within mRNA. This innovation was essential because, in its natural state, the body's immune system recognizes synthetic mRNA as foreign and initiates an inflammatory response, thereby destroying it before it can effectively instruct cells to produce proteins. By altering the specific building blocks of the mRNA molecule, their modification technique rendered it "invisible" to the immune system's detection mechanisms. This crucial step overcame a major obstacle, making mRNA a viable platform for therapeutic applications.
Overcoming Immune System Rejection

The primary barrier to using mRNA technology therapeutically had been the potent immune reaction it triggered. Messenger RNA, a natural molecule that carries genetic instructions for protein synthesis, becomes problematic when introduced artificially. Lab-made mRNA, if not modified, prompts an immediate immune attack. The nucleoside base modifications developed by Kariko and Weissman effectively circumvented this issue, allowing the synthetic mRNA to function as intended within the body without eliciting a harmful immune response. This enabled the mRNA to reach its target cells and guide them in producing the necessary antigens.
Enabling Widespread Vaccine Deployment

The success of their modifications directly contributed to the development of mRNA Covid-19 vaccines, such as the one co-developed by BioNTech and Pfizer. BioNTech reported that approximately 1.5 billion people globally received their mRNA vaccine, making it the most widely administered vaccine in Western countries. The ability to create a safe and effective mRNA vaccine rapidly, thanks to the foundational research by Kariko and Weissman, was instrumental in combating the pandemic, saving millions of lives, reducing severe illness, and facilitating the reopening of societies worldwide.
Impact on Protein Production and Therapeutic Potential

Messenger RNA functions as a biological blueprint, directing cells to produce specific proteins. Before Kariko and Weissman's work, the therapeutic use of synthetic mRNA was largely theoretical due to the immune system's aggressive response. Their discovery transformed mRNA from a scientifically interesting molecule into a practical tool for instructing human cells to generate therapeutic proteins. This pioneering work, commercially advanced during the pandemic by companies like BioNTech and Moderna, demonstrated the immense potential of mRNA technology for a range of future medical applications beyond Covid-19 vaccines.

Reading history

Hide →

This history is cleared when the page is closed.

How did Kariko and Weissman’s mRNA work enable Covid vaccines?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends